KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) FCF Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed FCF Margin for 9 consecutive years, with 33.55% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 699.0% to 33.55% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 22.18% through Dec 2025, down 151.0% year-over-year, with the annual reading at 20.08% for FY2025, 202.0% up from the prior year.
  • FCF Margin for Q4 2025 was 33.55% at Twist Bioscience, up from 38.38% in the prior quarter.
  • The five-year high for FCF Margin was 1.97% in Q2 2025, with the low at 154.4% in Q1 2022.
  • Average FCF Margin over 5 years is 63.52%, with a median of 36.44% recorded in 2025.
  • The sharpest move saw FCF Margin skyrocketed 21263bps in 2021, then plummeted -4881bps in 2022.
  • Over 5 years, FCF Margin stood at 141.45% in 2021, then increased by 14bps to 121.48% in 2022, then surged by 72bps to 34.24% in 2023, then grew by 22bps to 26.56% in 2024, then decreased by -26bps to 33.55% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 33.55%, 38.38%, and 1.97% for Q4 2025, Q3 2025, and Q2 2025 respectively.